Bamigboye A A, Morris J
Department of Obstetrics and Gynaecology, Mediclinic Private and Rob Feirrera Provincial Hospital, Suite 7B, Promenade Center, Louis Trichardt Street, Nelspruit, Mpumalanga, South Africa.
Cochrane Database Syst Rev. 2003;2003(3):CD004353. doi: 10.1002/14651858.CD004353.
Laboratory evidence in the 1940s demonstrated a positive role of placental hormones in the continuation of pregnancy. It was suggested that diethylstilbestrol was the oestrogen of choice for prevention of miscarriages. Observational studies were carried out with apparently positive results, on which clinical practice was based. This led to a worldwide usage of diethylstilbestrol despite controlled studies with contrary findings.
To determine the effects of antenatal administration of oestrogens, mainly diethylstilbestrol, on high risk and unselected pregnancy as regards miscarriages and other outcomes.
We searched the Pregnancy and Childbirth Group Specialised Register of controlled trials in November 2002.
Randomised and quasi-randomised trials were included.
Both reviewers extracted data from the studies identified that met the selection criteria, and the data were analysed using the RevMan software.
Miscarriage, preterm labour, low birthweight and stillbirth or neonatal death were not positively influenced by the intervention (diethylstilbestrol) as compared to the control group. Diethylstilbestrol in utero exposure led to increased rate of miscarriage and preterm birth. There was also an increase in the numbers of babies weighing less than 2500 grams. The maternal outcome in terms of pre-eclampsia was not influenced. Exposed female offsprings have a non-significant trend towards more cancer of the genital tract and cancer other than of the genital tract. Primary infertility, adenosis of the vagina/cervix in female offsprings, and testicular abnormality in male offsprings were significantly higher in those exposed to diethylstilbestrol before birth.
REVIEWER'S CONCLUSIONS: There was no benefit with the use of diethylstilbestrol in preventing miscarriages. Both short and long-term adverse outcomes in exposed offsprings were demonstration of the harm that this intervention caused women and their offspring during its usage.
20世纪40年代的实验室证据表明胎盘激素在维持妊娠方面具有积极作用。有人提出己烯雌酚是预防流产的首选雌激素。开展了观察性研究,结果显然是阳性的,并以此为临床实践的依据。尽管有对照研究得出了相反的结果,但这导致己烯雌酚在全球范围内被广泛使用。
确定产前使用雌激素(主要是己烯雌酚)对高危妊娠和未经过筛选的妊娠在流产及其他结局方面的影响。
我们于2002年11月检索了妊娠与分娩组对照试验专门注册库。
纳入随机和半随机试验。
两位综述作者从符合选择标准的研究中提取数据,并使用RevMan软件进行数据分析。
与对照组相比,干预措施(己烯雌酚)对流产、早产、低出生体重以及死产或新生儿死亡没有产生积极影响。子宫内接触己烯雌酚会导致流产率和早产率增加。体重不足2500克的婴儿数量也有所增加。子痫前期方面的产妇结局未受影响。暴露的女性后代患生殖道癌症和非生殖道癌症的趋势虽不显著但有所增加。出生前接触己烯雌酚的女性后代原发性不孕、阴道/宫颈腺病以及男性后代睾丸异常的发生率显著更高。
使用己烯雌酚预防流产并无益处。暴露后代的短期和长期不良结局都表明了这种干预措施在使用过程中对女性及其后代造成的危害。